Zobrazeno 1 - 3
of 3
pro vyhledávání: '"clinical trials-superficial"'
Autor:
Akke Bakker, Jacoba van der Zee, Geertjan van Tienhoven, H. Petra Kok, Coen R. N. Rasch, Hans Crezee
Publikováno v:
International Journal of Hyperthermia, Vol 36, Iss 1, Pp 1023-1038 (2019)
Objective: Hyperthermia therapy (HT), heating tumors to 40–45 °C, is a known radiotherapy (RT) and chemotherapy sensitizer. The additional benefit of HT to RT for recurrent breast cancer has been proven in multiple randomized trials. However, publ
Externí odkaz:
https://doaj.org/article/e0d5c3be630c4eb5b0062b2e972c9ded
Autor:
Jacoba van der Zee, Hans Crezee, H. Petra Kok, Geertjan van Tienhoven, A. Bakker, Coen R. N. Rasch
Publikováno v:
International Journal of Hyperthermia, Vol 36, Iss 1, Pp 1023-1038 (2019)
International Journal of Hyperthermia, 36(1), 1024-1039. TAYLOR & FRANCIS LTD
International Journal of Hyperthermia, 36(1), 1024-1039. Informa Healthcare
International Journal of Hyperthermia, 36(1), 1024-1039. TAYLOR & FRANCIS LTD
International Journal of Hyperthermia, 36(1), 1024-1039. Informa Healthcare
Objective: Hyperthermia therapy (HT), heating tumors to 40–45 °C, is a known radiotherapy (RT) and chemotherapy sensitizer. The additional benefit of HT to RT for recurrent breast cancer has been proven in multiple randomized trials. However, publ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e044373575009232a07a42b88b918fc2
https://doaj.org/article/e0d5c3be630c4eb5b0062b2e972c9ded
https://doaj.org/article/e0d5c3be630c4eb5b0062b2e972c9ded
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.